Characterization of Familial Myopathy and Paget Disease of Bone
NCT ID: NCT01166854
Last Updated: 2025-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25 participants
OBSERVATIONAL
2010-06-18
2030-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Diffuse Optical Spectroscopy will measure the concentrations of blood, water, and lipids (fats, for example) in your tissues. This device essentially measures the color of tissues in order to determine tissue physiology (its physical and chemical processes).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarker Development for Muscular Dystrophies
NCT05019625
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
NCT02109692
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy
NCT01671865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TheDiffuse Optical Spectroscopy measurement consists of placing a probe onto the surface of your body (calf, bicep, or head). This probe will be secured by either gentle hand pressure or fastened to your skin using clinically-approved wraps such as Coban/wrap bandages or medical adhesive tape and medical glues. Several dots will be made on your skin outlining the probe with a surgical felt tip marker. This is so we would be able to put the probe again on the same spot in case we needed to interrupt the measurement. The probe looks like a bar code scanner in a supermarket and it shines infrared light on your skin. There is no radiation involved with this light. In some cases where light signals are low, the optical detector will be placed directly onto your skin (but contained within an electronically shielded casing, and placed inside another plastic casing). (not offered during pregnancy).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Muscle weakness
Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diffuse Optical Spectroscopy
Diffuse Optical Spectroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a combination of medical problems including muscle and bone disease and their family members.
Exclusion Criteria
* unrelated diagnosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Virginia Kimonis
Virginia Kimonis, MD, MRCP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Virginia Kimonis, MD
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute University of California Irvine
Bruce Tromberg, PhD
Role: STUDY_DIRECTOR
Beckman Laser Institute University of California Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hewitt Hall
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20075832
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.